Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Inventory (2023 - 2024)

Seres Therapeutics (MCRB) has disclosed Inventory for 2 consecutive years, with $53.0 million as the latest value for Q2 2024.

  • Quarterly Inventory rose 892.45% to $53.0 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $53.0 million through Jun 2024, up 892.45% year-over-year, with the annual reading at $29.6 million for FY2023, N/A changed from the prior year.
  • Inventory hit $53.0 million in Q2 2024 for Seres Therapeutics, up from $42.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $53.0 million in Q2 2024 to a low of $5.3 million in Q2 2023.